Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Sleep Disorders

Free Subscription Articles published in Eur Respir J Retrieve available abstracts of 31 articles: HTML format

Single Articles

July 2022
1. JUSTEAU G, Gerves-Pinquie C, Jouvenot M, Pigeanne T, et al
   Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea.
   Eur Respir J. 2022;60.
   PubMed    
   
   
   
2. LECHAT B, Appleton S, Melaku YA, Hansen K, et al
   Comorbid insomnia and sleep apnoea is associated with all-cause mortality.
   Eur Respir J. 2022;60.
   PubMed     Abstract available
   
   
   June 2022
3. PEPIN JL, Eastwood P, Eckert DJ
   Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care.
   Eur Respir J. 2022;59.
   PubMed     Abstract available
   
   
   May 2022
4. LEVY P, Naughton MT, Tamisier R, Cowie MR, et al
   Sleep apnoea and heart failure.
   Eur Respir J. 2022;59.
   PubMed     Abstract available
   
   
   
5. PALM A, Grote L, Ekstrom M, Ljunggren M, et al
   Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment.
   Eur Respir J. 2022;59.
   PubMed    
   
   
   April 2022
6. CORTESE R, Sanz-Rubio D, Kheirandish-Gozal L, Marin JM, et al
   Epigenetic age acceleration in obstructive sleep apnoea is reversible with adherent treatment.
   Eur Respir J. 2022;59.
   PubMed    
   
   
   
7. GAMBINO F, Bonsignore MR
   Can CPAP protect from cancer incidence in obstructive sleep apnoea patients? No evidence yet.
   Eur Respir J. 2022;59.
   PubMed    
   
   
   
8. MARTINEZ-GARCIA MA, Levy P
   Some forgotten issues in sleep apnoea.
   Eur Respir J. 2022;59.
   PubMed    
   
   
   
9. OSORIO RS, Martinez-Garcia MA, Rapoport DM
   Sleep apnoea in the elderly: a great challenge for the future.
   Eur Respir J. 2021;59.
   PubMed     Abstract available
   
   
   
10. JUSTEAU G, Bailly S, Gerves-Pinquie C, Trzepizur W, et al
    Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy.
    Eur Respir J. 2022;59.
    PubMed     Abstract available
    
    
    February 2022
11. IP MS, Tse HF, Lam DC, Lui MM, et al
    Reply: High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea.
    Eur Respir J. 2022;59.
    PubMed    
    
    
    
12. MONNERET D
    High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations.
    Eur Respir J. 2022;59.
    PubMed    
    
    
    
13. LIU Y, Yang L, Stampfer MJ, Redline S, et al
    Physical activity, sedentary behaviour and incidence of obstructive sleep apnoea in three prospective US cohorts.
    Eur Respir J. 2022;59.
    PubMed     Abstract available
    
    
    November 2021
14. GAISL T, Turnbull CD, Weimann G, Unger S, et al
    BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN).
    Eur Respir J. 2021;58.
    PubMed    
    
    
    October 2021
15. FARRE R, Gozal D, Almendros I
    Human experimental models: seeking to enhance multiscale research in sleep apnoea.
    Eur Respir J. 2021;58.
    PubMed    
    
    
    
16. SCHIZA S, Levy P, Martinez-Garcia MA, Pepin JL, et al
    The search for realistic evidence on the outcomes of obstructive sleep apnoea.
    Eur Respir J. 2021;58.
    PubMed    
    
    
    
17. WALTZ X, Beaudin AE, Belaidi E, Raneri J, et al
    Impact of obstructive sleep apnoea and intermittent hypoxia on blood rheology: a translational study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available
    
    
    
18. HARKI O, Tamisier R, Pepin JL, Bailly S, et al
    VE-cadherin cleavage in sleep apnoea: new insights into intermittent hypoxia-related endothelial permeability.
    Eur Respir J. 2021;58.
    PubMed     Abstract available
    
    
    
19. LUI MM, Tse HF, Lam DC, Lau KK, et al
    Continuous positive airway pressure improves blood pressure and serum cardiovascular biomarkers in obstructive sleep apnoea and hypertension.
    Eur Respir J. 2021;58.
    PubMed     Abstract available
    
    
    May 2021
20. WANG H, Goodman MO, Sofer T, Redline S, et al
    Cutting the fat: advances and challenges in sleep apnoea genetics.
    Eur Respir J. 2021;57.
    PubMed    
    
    
    
21. DRAGER LF, Martinez-Garcia MA
    Thoracic aortic aneurysms: expanding the potential cardiovascular consequences of obstructive sleep apnoea.
    Eur Respir J. 2021;57.
    PubMed    
    
    
    
22. STRAUSZ S, Ruotsalainen S, Ollila HM, Karjalainen J, et al
    Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health.
    Eur Respir J. 2021;57.
    PubMed     Abstract available
    
    
    
23. GAISL T, Rejmer P, Roeder M, Baumgartner P, et al
    Obstructive sleep apnoea and the progression of thoracic aortic aneurysm: a prospective cohort study.
    Eur Respir J. 2021;57.
    PubMed     Abstract available
    
    
    March 2021
24. SCHIZA S, Simonds A, Randerath W, Fanfulla F, et al
    Sleep laboratories reopening and COVID-19: a European perspective.
    Eur Respir J. 2021;57.
    PubMed     Abstract available
    
    
    
25. BLANCHARD M, Gerves-Pinquie C, Feuilloy M, Le Vaillant M, et al
    Hypoxic burden and heart rate variability predict stroke incidence in sleep apnoea.
    Eur Respir J. 2021;57.
    PubMed    
    
    
    February 2021
26. BONSIGNORE MR, Randerath W, Schiza S, Verbraecken J, et al
    European Respiratory Society statement on sleep apnoea, sleepiness and driving risk.
    Eur Respir J. 2021;57.
    PubMed     Abstract available
    
    
    August 2020
27. ADIR Y, Humbert M, Chaouat A
    Sleep-related breathing disorders and pulmonary hypertension.
    Eur Respir J. 2020 Aug 3. pii: 13993003.02258-2020.
    PubMed     Abstract available
    
    
    May 2020
28. PENGO MF, Soranna D, Giontella A, Perger E, et al
    Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis.
    Eur Respir J. 2020;55.
    PubMed     Abstract available
    
    
    April 2020
29. PEPIN JL, Martinez-Garcia MA
    Sleep disorders and cerebrovascular disease: the long and winding road.
    Eur Respir J. 2020;55.
    PubMed    
    
    
    March 2020
30. BILLINGS ME, Levy P, Ayas N
    Suboptimal CPAP adherence: half a loaf is better than no bread at all.
    Eur Respir J. 2020;55.
    PubMed    
    
    
    May 2019
31. TAFELMEIER M, Knapp M, Lebek S, Floerchinger B, et al
    Predictors of delirium after cardiac surgery in patients with sleep-disordered breathing.
    Eur Respir J. 2019 May 20. pii: 13993003.00354-2019.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sleep Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: